" Yes, that's exactly my suspicion - that more frequent, lower doses could end up being more effective than the large doses that are standard at the moment
The study included 100,455 people in the combination GLP-1RA and SGLT2i group and 339,540 people in the comparison SGLT2i group across 3 cohorts: T2D with atherosclerotic cardiovascular disease (ASCVD), T2D, and T2D with chronic kidney disease (CKD)
Tang H, Lu Y, Donahoo WT, et al
Under hyperglycemia, lipids, proteins, and nuclear acids can form advanced glycation end products, interact with the corresponding receptor and finally trigger the activation of inflammation, oxidative stress, and mitochondrial dysfunction, which ultimately induces neuronal injury (4346)
Low starting dosages to help your body adjust Scale your dosages as needed Change medication in partnership with a licensed provider anytime, if eligible How it works Personalized Planning Start by exploring our plans and completing a quick history form
high blood pressure, type 2 diabetes) Reduce the risk of serious cardiovascular problems (e.g